Picture of Read Gene SA logo

RDG Read Gene SA Cashflow Statement

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Read Gene SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

2019
December 31st
R2020
December 31st
R2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
PAS
PAS
PAS
PAS
PAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.0770.3490.0380.213-1.35
Depreciation
Non-Cash Items-2.650.2761.070.3480.546
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.24-0.221-1.56-0.669-0.512
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-2.491.050.1060.348-0.821
Capital Expenditures-0.067-0.06-0.014-0.362
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.148-3.93
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.148-0.067-0.06-0.014-4.29
Financing Cash Flow Items2.67-0.135-0.06-0.225-0.401
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities3.310.19-0.06-0.229-0.401
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.6721.18-0.0140.105-5.51